Issue Date: April 25, 2016
Pharma R&D links industry, academia
The University of Chicago and AbbVie are joining to accelerate oncology drug discovery. Under the five-year agreement, AbbVie will provide funding to the university that may be used for preclinical research and clinical trials; it gains an option to exclusively license discoveries made under the agreement. Separately, Sanford Burnham Prebys (SBP) Medical Discovery Institute and GlaxoSmithKline have formed the SBP-GSK Center for Translational Neuroscience. Under a three-year agreement, GSK will support a research lab on SBP’s La Jolla, Calif., campus.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society